Biomerica (BMRA)
(Delayed Data from NSDQ)
$0.28 USD
-0.04 (-11.51%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.28 0.00 (-0.21%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Biomerica, Inc falls in the month of May .
All items in Millions except EPS data.
5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 | |
---|---|---|---|---|---|
Sales | 5 | 5 | 19 | 7 | 7 |
Cost Of Goods | 5 | 5 | 16 | 7 | 5 |
Gross Profit | 1 | 0 | 3 | 1 | 2 |
Selling & Adminstrative & Depr. & Amort Expenses | 7 | 8 | 8 | 7 | 4 |
Income After Depreciation & Amortization | -6 | -7 | -5 | -7 | -2 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -6 | -7 | -5 | -6 | -2 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -6 | -7 | -5 | -6 | -2 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -6 | -7 | -5 | -6 | -2 |
Depreciation Footnote | 5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -6 | -7 | -4 | -6 | -2 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 1 | 0 | 0 |
Income After Depreciation & Amortization | -6 | -7 | -5 | -7 | -2 |
Earnings Per Share Data | 5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 |
---|---|---|---|---|---|
Average Shares | 16.82 | 14.15 | 12.67 | 11.93 | 10.17 |
Diluted EPS Before Non-Recurring Items | -0.36 | -0.50 | -0.36 | -0.54 | -0.23 |
Diluted Net EPS (GAAP) | -0.36 | -0.50 | -0.36 | -0.54 | -0.23 |
Fiscal Year end for Biomerica, Inc falls in the month of May .
All items in Millions except EPS data.
8/31/24 | 5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1.12 | 1.02 | 1.57 | 1.71 |
Cost Of Goods | NA | 1.10 | 1.17 | 1.24 | 1.30 |
Gross Profit | NA | 0.02 | -0.15 | 0.33 | 0.41 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1.55 | 1.85 | 1.93 | 1.64 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -1.53 | -2.00 | -1.60 | -1.23 |
Non-Operating Income | NA | 0.11 | 0.09 | 0.11 | 0.12 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -1.41 | -1.91 | -1.50 | -1.11 |
Income Taxes | NA | 0.01 | 0.00 | 0.01 | 0.02 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.42 | -1.92 | -1.51 | -1.13 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.42 | -1.92 | -1.51 | -1.13 |
Earnings Per Share Data | 8/31/24 | 5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 16.82 | 16.82 | 16.82 | 16.82 |
Diluted EPS Before Non-Recurring Items | NA | -0.09 | -0.11 | -0.09 | -0.07 |
Diluted Net EPS (GAAP) | NA | -0.09 | -0.11 | -0.09 | -0.07 |